Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy

Hormone therapy (HT) is an effective treatment for metastatic endometrial carcinoma (mEC), with limited toxicity and low cost. We focused on molecular analysis of mECs treated by HT and, for the first time to date, we compared the genomic profiles of paired metastasis and primary ECs. The main objec...

Descripción completa

Detalles Bibliográficos
Autores principales: Neron, Mathias, Guille, Arnaud, Allegre, Lucie, Colombo, Pierre-Emmanuel, Leaha, Cristina, Adelaide, José, Carbuccia, Nadine, Courtier, Frédéric, Boissiere, Florence, Crapez, Evelyne, Fabbro, Michel, Gouy, Sébastien, Mamessier, Emilie, Lambaudie, Éric, Birnbaum, Daniel, Bertucci, François, Chaffanet, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143816/
https://www.ncbi.nlm.nih.gov/pubmed/35629078
http://dx.doi.org/10.3390/jpm12050655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143816/
https://www.ncbi.nlm.nih.gov/pubmed/35629078
http://dx.doi.org/10.3390/jpm12050655

Ejemplares similares